Explore Our Services

What We Offer

Keystone Biologics Advisory provides principal-led CMC and regulatory advice for complex biologics, including cell and gene therapies. We support programs at every stage, from early discovery and investor readiness, through first-in-human trials in Australia and the US, to BLA submission.

Every engagement is tailored to your candidate, your stage of development and your next milestone.

  • Early discovery and preclinical: see Discovery to FIH Readiness and Target Product Profile

  • Preparing for clinical trials: see INTERACT, Pre-IND Meetings, IND and BLA, and Regulatory Strategy

  • Clinical development to licensure: see Strategic CMC Advisory Services

Our Services

TPP · CTN · Pre-IND Meetings · IND · BLA · CMC Advisory · Regulatory Strategy · Cell and Gene Therapies · INTERACT ·

TPP · CTN · Pre-IND Meetings · IND · BLA · CMC Advisory · Regulatory Strategy · Cell and Gene Therapies · INTERACT ·

Not sure where to start?
Tell us about your modality and your next milestone, and we'll suggest the most useful first step.